BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 102 hits Enz. Inhib. hit(s) with Target = 'Galactokinase (GALK)' AND taxid = 9606   
Target
(Institution)
LigandTarget
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249789
PNG
(US9447087, 17 | US9447087, 57)
Show SMILES Clc1ccccc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C21H17ClN4O2/c22-13-7-2-1-6-12(13)19-18-15(9-5-10-16(18)27)23-20(25-19)26-21-24-14-8-3-4-11-17(14)28-21/h1-4,6-8,11,19H,5,9-10H2,(H2,23,24,25,26)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 595n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249831
PNG
(US9447087, 67)
Show SMILES Brc1cccnc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C20H16BrN5O2/c21-11-5-4-10-22-17(11)18-16-13(7-3-8-14(16)27)23-19(25-18)26-20-24-12-6-1-2-9-15(12)28-20/h1-2,4-6,9-10,18H,3,7-8H2,(H2,23,24,25,26)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 651n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM50380337
PNG
(CHEMBL2017798)
Show SMILES Oc1ccc(O)c(c1)C1NC(=O)C(C#N)=C(SCc2ccccc2)S1
Show InChI InChI=1S/C18H14N2O3S2/c19-9-14-16(23)20-17(13-8-12(21)6-7-15(13)22)25-18(14)24-10-11-4-2-1-3-5-11/h1-8,17,21-22H,10H2,(H,20,23)
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

AffyNet 
Article
n/an/a 700n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human galactokinase after 30 mins by Kinase-GloTM assay


Citation and Details
More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249808
PNG
(US9447087, 41)
Show SMILES Brc1ccccc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C21H17BrN4O2/c22-13-7-2-1-6-12(13)19-18-15(9-5-10-16(18)27)23-20(25-19)26-21-24-14-8-3-4-11-17(14)28-21/h1-4,6-8,11,19H,5,9-10H2,(H2,23,24,25,26)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 749n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM50380339
PNG
(CHEMBL2017800)
Show SMILES Oc1ccc(O)c(c1)C1NC(=O)C(C#N)=C(SCc2cccc(c2)N2CCOCC2)S1
Show InChI InChI=1S/C22H21N3O4S2/c23-12-18-20(28)24-21(17-11-16(26)4-5-19(17)27)31-22(18)30-13-14-2-1-3-15(10-14)25-6-8-29-9-7-25/h1-5,10-11,21,26-27H,6-9,13H2,(H,24,28)
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

AffyNet 
Article
n/an/a 900n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human galactokinase after 30 mins by Kinase-GloTM assay


Citation and Details
More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249793
PNG
(US9447087, 22)
Show SMILES O=C1CCCC2=C1C1(CCSCC1)N=C(Nc1nc3ccccc3o1)N2
Show InChI InChI=1S/C19H20N4O2S/c24-14-6-3-5-13-16(14)19(8-10-26-11-9-19)23-17(20-13)22-18-21-12-4-1-2-7-15(12)25-18/h1-2,4,7H,3,5-6,8-11H2,(H2,20,21,22,23)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 1.06E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249830
PNG
(US9447087, 66)
Show SMILES Ic1ccccc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C21H17IN4O2/c22-13-7-2-1-6-12(13)19-18-15(9-5-10-16(18)27)23-20(25-19)26-21-24-14-8-3-4-11-17(14)28-21/h1-4,6-8,11,19H,5,9-10H2,(H2,23,24,25,26)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 1.16E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM50380336
PNG
(CHEMBL2017797)
Show SMILES Oc1ccc(C2NC(=O)C(C#N)=C(SCc3ccccc3)S2)c(O)c1
Show InChI InChI=1S/C18H14N2O3S2/c19-9-14-16(23)20-17(13-7-6-12(21)8-15(13)22)25-18(14)24-10-11-4-2-1-3-5-11/h1-8,17,21-22H,10H2,(H,20,23)
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

AffyNet 
Article
n/an/a 1.20E+3n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human galactokinase after 30 mins by Kinase-GloTM assay


Citation and Details
More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM50380338
PNG
(CHEMBL2017799)
Show SMILES Oc1ccc(cc1O)C1NC(=O)C(C#N)=C(SCc2cccc(c2)N2CCOCC2)S1
Show InChI InChI=1S/C22H21N3O4S2/c23-12-17-20(28)24-21(15-4-5-18(26)19(27)11-15)31-22(17)30-13-14-2-1-3-16(10-14)25-6-8-29-9-7-25/h1-5,10-11,21,26-27H,6-9,13H2,(H,24,28)
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

AffyNet 
Article
n/an/a 1.20E+3n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human galactokinase after 30 mins by Kinase-GloTM assay


Citation and Details
More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM50380331
PNG
(CHEMBL1835517)
Show SMILES Oc1ccc(cc1O)C1NC(=O)C(C#N)=C(SCc2ccccc2)S1
Show InChI InChI=1S/C18H14N2O3S2/c19-9-13-16(23)20-17(12-6-7-14(21)15(22)8-12)25-18(13)24-10-11-4-2-1-3-5-11/h1-8,17,21-22H,10H2,(H,20,23)
GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem

Similars

AffyNet 
Article
n/an/a 1.40E+3n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human galactokinase after 30 mins by Kinase-GloTM assay


Citation and Details
More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249832
PNG
(US9447087, 68 | US9447087, 71)
Show SMILES Brc1cnccc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C20H16BrN5O2/c21-12-10-22-9-8-11(12)18-17-14(5-3-6-15(17)27)23-19(25-18)26-20-24-13-4-1-2-7-16(13)28-20/h1-2,4,7-10,18H,3,5-6H2,(H2,23,24,25,26)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 1.46E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM50380333
PNG
(CHEMBL2017794)
Show SMILES Oc1ccc(cc1)C1NC(=O)C(C#N)=C(SCc2ccccc2)S1
Show InChI InChI=1S/C18H14N2O2S2/c19-10-15-16(22)20-17(13-6-8-14(21)9-7-13)24-18(15)23-11-12-4-2-1-3-5-12/h1-9,17,21H,11H2,(H,20,22)
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

AffyNet 
Article
n/an/a 1.80E+3n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human galactokinase after 30 mins by Kinase-GloTM assay


Citation and Details
More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM50380330
PNG
(CHEMBL2017801)
Show SMILES Oc1ccc(cc1)C1NC(=O)C(C#N)=C(SCc2cccc(c2)N2CCOCC2)S1
Show InChI InChI=1S/C22H21N3O3S2/c23-13-19-20(27)24-21(16-4-6-18(26)7-5-16)30-22(19)29-14-15-2-1-3-17(12-15)25-8-10-28-11-9-25/h1-7,12,21,26H,8-11,14H2,(H,24,27)
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

AffyNet 
Article
n/an/a 2.40E+3n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of human galactokinase after 30 mins by Kinase-GloTM assay


Citation and Details
More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249789
PNG
(US9447087, 17 | US9447087, 57)
Show SMILES Clc1ccccc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C21H17ClN4O2/c22-13-7-2-1-6-12(13)19-18-15(9-5-10-16(18)27)23-20(25-19)26-21-24-14-8-3-4-11-17(14)28-21/h1-4,6-8,11,19H,5,9-10H2,(H2,23,24,25,26)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 2.66E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249792
PNG
(US9447087, 21)
Show SMILES O=C1CCCC2=C1C1(CCSC1)N=C(Nc1nc3ccccc3o1)N2
Show InChI InChI=1/C18H18N4O2S/c23-13-6-3-5-12-15(13)18(8-9-25-10-18)22-16(19-12)21-17-20-11-4-1-2-7-14(11)24-17/h1-2,4,7H,3,5-6,8-10H2,(H2,19,20,21,22)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 2.66E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249833
PNG
(US9447087, 69)
Show SMILES Brc1c[nH]nc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C18H15BrN6O2/c19-9-8-20-25-15(9)16-14-11(5-3-6-12(14)26)21-17(23-16)24-18-22-10-4-1-2-7-13(10)27-18/h1-2,4,7-8,16H,3,5-6H2,(H,20,25)(H2,21,22,23,24)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 2.91E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249838
PNG
(US9447087, 75)
Show SMILES Clc1c[nH]nc1C1NC(Nc2nc3ccccc3o2)=NC2=C1C(=O)CCC2
Show InChI InChI=1/C18H15ClN6O2/c19-9-8-20-25-15(9)16-14-11(5-3-6-12(14)26)21-17(23-16)24-18-22-10-4-1-2-7-13(10)27-18/h1-2,4,7-8,16H,3,5-6H2,(H,20,25)(H2,21,22,23,24)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 2.91E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249834
PNG
(US9447087, 70)
Show SMILES Cn1cc(Br)c(n1)C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C19H17BrN6O2/c1-26-9-10(20)16(25-26)17-15-12(6-4-7-13(15)27)21-18(23-17)24-19-22-11-5-2-3-8-14(11)28-19/h2-3,5,8-9,17H,4,6-7H2,1H3,(H2,21,22,23,24)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 2.91E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249855
PNG
(US9447087, 93)
Show SMILES CC1=C(C(=O)Nc2nncs2)C2(CCCC2)N=C(Nc2nc3ccccc3o2)N1
Show InChI InChI=1S/C19H19N7O2S/c1-11-14(15(27)23-18-26-20-10-29-18)19(8-4-5-9-19)25-16(21-11)24-17-22-12-6-2-3-7-13(12)28-17/h2-3,6-7,10H,4-5,8-9H2,1H3,(H,23,26,27)(H2,21,22,24,25)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 3.26E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249849
PNG
(US9447087, 86)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1ccccc1Br)C(=O)Nc1nncs1
Show InChI InChI=1/C21H16BrN7O2S/c1-11-16(18(30)27-21-29-23-10-32-21)17(12-6-2-3-7-13(12)22)26-19(24-11)28-20-25-14-8-4-5-9-15(14)31-20/h2-10,17H,1H3,(H,27,29,30)(H2,24,25,26,28)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 3.26E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249844
PNG
(US9447087, 81)
Show SMILES COc1ccc(NC(=O)C2=C(C)NC(Nc3nc4ccccc4o3)=NC2c2ccccc2Br)cc1
Show InChI InChI=1/C26H22BrN5O3/c1-15-22(24(33)29-16-11-13-17(34-2)14-12-16)23(18-7-3-4-8-19(18)27)31-25(28-15)32-26-30-20-9-5-6-10-21(20)35-26/h3-14,23H,1-2H3,(H,29,33)(H2,28,30,31,32)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 3.26E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249839
PNG
(US9447087, 76)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1ccccc1Br)C(=O)Nc1ccccc1Cl
Show InChI InChI=1/C25H19BrClN5O2/c1-14-21(23(33)29-18-11-5-4-10-17(18)27)22(15-8-2-3-9-16(15)26)31-24(28-14)32-25-30-19-12-6-7-13-20(19)34-25/h2-13,22H,1H3,(H,29,33)(H2,28,30,31,32)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 3.26E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249843
PNG
(US9447087, 80)
Show SMILES COc1ccccc1NC(=O)C1=C(C)NC(Nc2nc3ccccc3o2)=NC1c1ccccc1Br
Show InChI InChI=1/C26H22BrN5O3/c1-15-22(24(33)29-18-11-5-7-13-20(18)34-2)23(16-9-3-4-10-17(16)27)31-25(28-15)32-26-30-19-12-6-8-14-21(19)35-26/h3-14,23H,1-2H3,(H,29,33)(H2,28,30,31,32)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 3.66E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249862
PNG
(US9447087, 100)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1nn(C)cc1Cl)C(=O)Nc1nnc(s1)-c1ccccc1
Show InChI InChI=1/C25H20ClN9O2S/c1-13-18(21(36)30-25-33-32-22(38-25)14-8-4-3-5-9-14)20(19-15(26)12-35(2)34-19)29-23(27-13)31-24-28-16-10-6-7-11-17(16)37-24/h3-12,20H,1-2H3,(H,30,33,36)(H2,27,28,29,31)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 3.66E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249842
PNG
(US9447087, 79)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1ccccc1Br)C(=O)Nc1ccc(C)cc1
Show InChI InChI=1/C26H22BrN5O2/c1-15-11-13-17(14-12-15)29-24(33)22-16(2)28-25(31-23(22)18-7-3-4-8-19(18)27)32-26-30-20-9-5-6-10-21(20)34-26/h3-14,23H,1-2H3,(H,29,33)(H2,28,30,31,32)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 4.11E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249848
PNG
(US9447087, 85)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1ccccc1Br)C(=O)Nc1nccs1
Show InChI InChI=1/C22H17BrN6O2S/c1-12-17(19(30)28-22-24-10-11-32-22)18(13-6-2-3-7-14(13)23)27-20(25-12)29-21-26-15-8-4-5-9-16(15)31-21/h2-11,18H,1H3,(H,24,28,30)(H2,25,26,27,29)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 4.11E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249779
PNG
(US9447087, 4)
Show SMILES O=C1CCCC2=C1C1(CCCC1)N=C(Nc1nc3ccccc3o1)N2
Show InChI InChI=1S/C19H20N4O2/c24-14-8-5-7-13-16(14)19(10-3-4-11-19)23-17(20-13)22-18-21-12-6-1-2-9-15(12)25-18/h1-2,6,9H,3-5,7-8,10-11H2,(H2,20,21,22,23)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 4.21E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249841
PNG
(US9447087, 78)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1ccccc1Br)C(=O)Nc1ccccc1C
Show InChI InChI=1/C26H22BrN5O2/c1-15-9-3-6-12-19(15)29-24(33)22-16(2)28-25(31-23(22)17-10-4-5-11-18(17)27)32-26-30-20-13-7-8-14-21(20)34-26/h3-14,23H,1-2H3,(H,29,33)(H2,28,30,31,32)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 4.61E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249840
PNG
(US9447087, 77)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1ccccc1Br)C(=O)Nc1ccc(Cl)cc1
Show InChI InChI=1/C25H19BrClN5O2/c1-14-21(23(33)29-16-12-10-15(27)11-13-16)22(17-6-2-3-7-18(17)26)31-24(28-14)32-25-30-19-8-4-5-9-20(19)34-25/h2-13,22H,1H3,(H,29,33)(H2,28,30,31,32)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 5.17E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249868
PNG
(US9447087, 108)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1n[nH]cc1Cl)C(=O)Nc1nnc(s1)-c1ccccc1
Show InChI InChI=1/C24H18ClN9O2S/c1-12-17(20(35)30-24-34-33-21(37-24)13-7-3-2-4-8-13)19(18-14(25)11-26-32-18)29-22(27-12)31-23-28-15-9-5-6-10-16(15)36-23/h2-11,19H,1H3,(H,26,32)(H,30,34,35)(H2,27,28,29,31)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 5.17E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249782
PNG
(US9447087, 7)
Show SMILES CC1(C)CC(=O)C2=C(C1)NC(Nc1nc3ccccc3o1)=NC21CCCCC1
Show InChI InChI=1S/C22H26N4O2/c1-21(2)12-15-18(16(27)13-21)22(10-6-3-7-11-22)26-19(23-15)25-20-24-14-8-4-5-9-17(14)28-20/h4-5,8-9H,3,6-7,10-13H2,1-2H3,(H2,23,24,25,26)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 5.17E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249864
PNG
(US9447087, 102)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1nn(C)cc1Cl)C(=O)Nc1nncs1
Show InChI InChI=1/C19H16ClN9O2S/c1-9-13(16(30)25-19-27-21-8-32-19)15(14-10(20)7-29(2)28-14)24-17(22-9)26-18-23-11-5-3-4-6-12(11)31-18/h3-8,15H,1-2H3,(H,25,27,30)(H2,22,23,24,26)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 5.17E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249847
PNG
(US9447087, 84)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1ccccc1Br)C(=O)Nc1ccon1
Show InChI InChI=1/C22H17BrN6O3/c1-12-18(20(30)26-17-10-11-31-29-17)19(13-6-2-3-7-14(13)23)27-21(24-12)28-22-25-15-8-4-5-9-16(15)32-22/h2-11,19H,1H3,(H,26,29,30)(H2,24,25,27,28)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 5.80E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249796
PNG
(US9447087, 26)
Show SMILES Cc1ccc2oc(NC3=NC4(CCCC4)C4=C(CCCC4=O)N3)nc2c1
Show InChI InChI=1S/C20H22N4O2/c1-12-7-8-16-14(11-12)22-19(26-16)23-18-21-13-5-4-6-15(25)17(13)20(24-18)9-2-3-10-20/h7-8,11H,2-6,9-10H2,1H3,(H2,21,22,23,24)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 5.95E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249856
PNG
(US9447087, 94)
Show SMILES CC1=C(C(=O)Nc2ccon2)C2(CCCC2)N=C(Nc2nc3ccccc3o2)N1
Show InChI InChI=1S/C20H20N6O3/c1-12-16(17(27)23-15-8-11-28-26-15)20(9-4-5-10-20)25-18(21-12)24-19-22-13-6-2-3-7-14(13)29-19/h2-3,6-8,11H,4-5,9-10H2,1H3,(H,23,26,27)(H2,21,22,24,25)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 6.51E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249854
PNG
(US9447087, 92)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1ccccc1Br)C(=O)NCc1ccccc1
Show InChI InChI=1/C26H22BrN5O2/c1-16-22(24(33)28-15-17-9-3-2-4-10-17)23(18-11-5-6-12-19(18)27)31-25(29-16)32-26-30-20-13-7-8-14-21(20)34-26/h2-14,23H,15H2,1H3,(H,28,33)(H2,29,30,31,32)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 6.51E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249783
PNG
(US9447087, 8)
Show SMILES CC1(C)CC(=O)C2=C(C1)NC(Nc1nc3ccccc3o1)=NC21CCCC1
Show InChI InChI=1S/C21H24N4O2/c1-20(2)11-14-17(15(26)12-20)21(9-5-6-10-21)25-18(22-14)24-19-23-13-7-3-4-8-16(13)27-19/h3-4,7-8H,5-6,9-12H2,1-2H3,(H2,22,23,24,25)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 6.68E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249791
PNG
(US9447087, 20)
Show SMILES Clc1ccc2oc(NC3=NC4(CCCC4)C4=C(CCCC4=O)N3)nc2c1
Show InChI InChI=1S/C19H19ClN4O2/c20-11-6-7-15-13(10-11)22-18(26-15)23-17-21-12-4-3-5-14(25)16(12)19(24-17)8-1-2-9-19/h6-7,10H,1-5,8-9H2,(H2,21,22,23,24)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 6.68E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249823
PNG
(US9447087, 58)
Show SMILES FC(F)(F)c1cccnc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C21H16F3N5O2/c22-21(23,24)11-5-4-10-25-17(11)18-16-13(7-3-8-14(16)30)26-19(28-18)29-20-27-12-6-1-2-9-15(12)31-20/h1-2,4-6,9-10,18H,3,7-8H2,(H2,26,27,28,29)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 6.68E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249824
PNG
(US9447087, 59)
Show SMILES FC(F)(F)c1ccncc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C21H16F3N5O2/c22-21(23,24)12-8-9-25-10-11(12)18-17-14(5-3-6-15(17)30)26-19(28-18)29-20-27-13-4-1-2-7-16(13)31-20/h1-2,4,7-10,18H,3,5-6H2,(H2,26,27,28,29)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 6.68E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM2764
PNG
(2-(benzo[d]oxazol-2-ylamino)-4',5',7,8-tetrahydro-...)
Show SMILES CCCCCC=C(c1cc(Cl)c(OC)c(c1)C(=O)OC)c1cc(Cl)c(OC)c(c1)C(=O)OC
Show InChI InChI=1S/C25H28Cl2O6/c1-6-7-8-9-10-17(15-11-18(24(28)32-4)22(30-2)20(26)13-15)16-12-19(25(29)33-5)23(31-3)21(27)14-16/h10-14H,6-9H2,1-5H3
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Patents


Similars

AffyNet 
US Patent
n/an/a 6.68E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249797
PNG
(US9447087, 27)
Show SMILES Brc1ccc2oc(NC3=NC4(CCCC4)C4=C(CCCC4=O)N3)nc2c1
Show InChI InChI=1S/C19H19BrN4O2/c20-11-6-7-15-13(10-11)22-18(26-15)23-17-21-12-4-3-5-14(25)16(12)19(24-17)8-1-2-9-19/h6-7,10H,1-5,8-9H2,(H2,21,22,23,24)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 7.49E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249859
PNG
(US9447087, 112 | US9447087, 97)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1nn(C)cc1Cl)C(=O)Nc1ccon1
Show InChI InChI=1/C20H17ClN8O3/c1-10-15(18(30)24-14-7-8-31-28-14)17(16-11(21)9-29(2)27-16)25-19(22-10)26-20-23-12-5-3-4-6-13(12)32-20/h3-9,17H,1-2H3,(H,24,28,30)(H2,22,23,25,26)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 8.19E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249803
PNG
(US9447087, 36)
Show SMILES O=C1CCCC2=C1C1(CCOCC1)N=C(Nc1nc3ccccc3o1)N2
Show InChI InChI=1S/C19H20N4O3/c24-14-6-3-5-13-16(14)19(8-10-25-11-9-19)23-17(20-13)22-18-21-12-4-1-2-7-15(12)26-18/h1-2,4,7H,3,5-6,8-11H2,(H2,20,21,22,23)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 8.41E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249829
PNG
(US9447087, 65)
Show SMILES Cc1ccsc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2
Show InChI InChI=1/C20H18N4O2S/c1-11-9-10-27-18(11)17-16-13(6-4-7-14(16)25)21-19(23-17)24-20-22-12-5-2-3-8-15(12)26-20/h2-3,5,8-10,17H,4,6-7H2,1H3,(H2,21,22,23,24)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 9.19E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249860
PNG
(US9447087, 98)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1nn(C)cc1Cl)C(=O)Nc1nc2ccccc2s1
Show InChI InChI=1/C24H19ClN8O2S/c1-12-18(21(34)30-24-28-15-8-4-6-10-17(15)36-24)20(19-13(25)11-33(2)32-19)29-22(26-12)31-23-27-14-7-3-5-9-16(14)35-23/h3-11,20H,1-2H3,(H,28,30,34)(H2,26,27,29,31)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 9.19E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249852
PNG
(US9447087, 90)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1ccccc1Br)C(=O)Nc1ccccc1
Show InChI InChI=1/C25H20BrN5O2/c1-15-21(23(32)28-16-9-3-2-4-10-16)22(17-11-5-6-12-18(17)26)30-24(27-15)31-25-29-19-13-7-8-14-20(19)33-25/h2-14,22H,1H3,(H,28,32)(H2,27,29,30,31)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 9.19E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249851
PNG
(US9447087, 89)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1ccccc1Br)C(=O)NC1CCCCC1
Show InChI InChI=1/C25H26BrN5O2/c1-15-21(23(32)28-16-9-3-2-4-10-16)22(17-11-5-6-12-18(17)26)30-24(27-15)31-25-29-19-13-7-8-14-20(19)33-25/h5-8,11-14,16,22H,2-4,9-10H2,1H3,(H,28,32)(H2,27,29,30,31)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 9.19E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249859
PNG
(US9447087, 112 | US9447087, 97)
Show SMILES CC1=C(C(N=C(Nc2nc3ccccc3o2)N1)c1nn(C)cc1Cl)C(=O)Nc1ccon1
Show InChI InChI=1/C20H17ClN8O3/c1-10-15(18(30)24-14-7-8-31-28-14)17(16-11(21)9-29(2)27-16)25-19(22-10)26-20-23-12-5-3-4-6-13(12)32-20/h3-9,17H,1-2H3,(H,24,28,30)(H2,22,23,25,26)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 9.19E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Galactokinase (GALK)


(Homo sapiens (Human))
BDBM249788
PNG
(US9447087, 16)
Show SMILES Clc1ccccc1C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CC2
Show InChI InChI=1/C20H15ClN4O2/c21-12-6-2-1-5-11(12)18-17-14(9-10-15(17)26)22-19(24-18)25-20-23-13-7-3-4-8-16(13)27-20/h1-8,18H,9-10H2,(H2,22,23,24,25)
GoogleScholar
AffyNet 
UniChem
AffyNet 
US Patent
n/an/a 9.43E+3n/an/an/an/an/an/a



UNIVERSITY OF UTAH RESEARCH FOUNDATION

US Patent


Assay Description
Assay details and protocol: The primary assay monitored ATP depletion using Promega's KinaseGlo technology, where ATP levels are measured through...


US Patent US9447087 (2016)

More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 102 total )  |  Next  |  Last  >>
Jump to: